Crinetics Pharmaceuticals

-$2.29 (-11.65%) Today
-$0.02 (-0.12%) As of 11:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRNX and other ETFs, options, and stocks.

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.

CEO
Scott R. Struthers
Employees
143
Headquarters
San Diego, California
Founded
2008

CRNX Key Statistics

Market cap
929.40M
Price-Earnings ratio
—
Dividend yield
—
Average volume
390.88K
High today
$19.59
Low today
$16.79
Open price
$19.59
Volume
660.36K
52 Week high
$28.95
52 Week low
$16.20

CRNX Earnings

-$0.73
-$0.66
-$0.60
-$0.53
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.58 per share
Actual
-$0.73 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure